How to Avoid Nephrogenic Systemic Fibrosis: Current Guidelines in Europe and the United States

Radiologic Clinics of North America

Volumn 47, Issue 5, 2009, Pages 871-875

  Thomsen, Henrik S ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Gadolinium based contrast media; Glomerular filtration rate; Guidelines; Late adverse reactions; Nephrogenic systemic fibrosis

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GADOTERIDOL; GADOVERSETAMIDE;

DRUG CONTRAINDICATION; DRUG USE; EUROPE; FOOD AND DRUG ADMINISTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; NEPHROGENIC SYSTEMIC FIBROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

CONTRAST MEDIA; EUROPE; GADOLINIUM; HUMANS; KIDNEY FUNCTION TESTS; NEPHROGENIC FIBROSING DERMOPATHY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED STATES;

EID: 69649101256     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2009.05.002     Document Type: Review

References (16)

1. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
2. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
3. Thomsen H.S. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 16 (2006) 2619-2621
4. Broome D.R., Girguis M., Baron P., et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188 (2007) 586-592
5. Sadowski E., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 43 (2007) 148-157
6. EMEA. Public assessment report. Increased risk of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis and gadolinium-containing MRI contrast agents. Available at: (June 26th, 2007). http://www.esur.org/fileadmin/NSF/Public_Assessment_Report_NSF_Gadolinium_26_June_2007.pdf Accessed April 9, 2009
7. Kanal E., Broome D.R., Martin D.R., et al. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology 246 (2008) 11-14
8. Dawson P., and Punwani S. Nephrogenic systemic fibrosis: non-gadolinium options for the imaging of CKD/ESRD patients. Semin Dial 21 (2008) 160-165
9. Thomsen H.S., Morcos S.K., and Barrett B.J. Contrast-induced nephropathy: The wheel has turned 360 degrees. Acta Radiol 49 (2008) 646-657
10. Thomsen H.S. Delayed reactions: nephrogenic systemic fibrosis. In: Thomsen H.S., and Webb J.A.W. (Eds). Contrast media: safety issues and ESUR guidelines. 2nd revised edition (2009), Springer Verlag, Heidelberg (Germany) 187-196
11. Thomsen H.S. Contrast medium-induced nephropathy. In: Thomsen H.S., and Webb J.A.W. (Eds). Contrast media: safety issues and ESUR guidelines. 2nd revised edition (2009), Springer Verlag, Heidelberg (Germany) 63-80
12. Stenver D.I. Pharmacovigilance: what to do if you see an adverse reaction and the consequences. Eur J Radiol 66 (2008) 184-186
13. Thomsen H.S. Guidelines on contrast media. In: Thomsen H.S., and Webb J.A.W. (Eds). Contrast media: safety issues and ESUR guidelines. 2nd revised edition (2009), Springer Verlag, Heidelberg (Germany) 229-242
14. European Society of Magnetic Resonance in Medicine and Biology. ESMRMB recommendations on adverse reactions to gadolinium based on contrast agents. Available at:http://www.esmrmb.org/html/img/pool/ESMRMB__recommendation_on_NSF.pdfAccessed April 9, 2009
15. Kanal E., Barkovich A.J., Bell C., et al. ACR blue ribbon panel on MR safety. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 188 (2007) 1447-1474
16. American College of Radiology. Manual on contrast media version 6.0 with changes until September 2008. Available at:. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual.aspx Accessed April 9, 2009